ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataShowing 20 of 12219 recruiting trials
Durvalumab With Gemcitabine and Cisplatin for the Treatment of High-Risk Resectable Liver Cancer Before Surgery
👨⚕️ Hop S Tran Cao, University of Texas MD Anderson Cancer Center LAO📍 58 sites📅 Started Jul 2024View details ↗
Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL).
A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy
Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
Personalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening
RecruitingNCT05887700 ↗
Lifetech CeraFlex™ ASD Closure System Post-Market Clinical Follow-Up
RecruitingNCT05891379 ↗
Inebilizumab in Acute Neuromyelitis Optica Spectrum Disorders
Siltuximab for the Prevention of Severe Immune-Related Adverse Events During Immune Checkpoint Inhibitor Rechallenge in Patients With Advanced Cancer, CIRES Trial
👨⚕️ Yuanquan Yang, MD, PhD, Ohio State University Comprehensive Cancer Center📍 1 site📅 Started Jul 2024View details ↗
SalT Supplementation in Older Adults With Orthostatic Intolerance Disorders
RecruitingNCT06875700 ↗
Beliefs, Attitudes, and Response to Genetic Testing in SarcomaPatients
A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer
👨⚕️ Fiona Thistlethwaite, Prof, The Christie NHS Foundation Trust📍 2 sites📅 Started Jul 2024View details ↗
A Study of AMDX-2011P in Participants With CAA
RecruitingNCT06685055 ↗
Markers of Favorable Response to FcRn Inhibitors(INFORM)
👨⚕️ Raffaele Iorio, Fondazione Policlinico Universitario A. Gemelli, IRCCS📍 1 site📅 Started Jul 2024View details ↗
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
RecruitingNCT06422975 ↗
Registry of Patients in Shock Treated With Vasopressin
👨⚕️ Raquel García Álvarez, Hospital Universitario 12 de Octubre📍 24 sites📅 Started Jul 2024View details ↗
Characterization and Support for Neurodevelopmental Disorders Associated With Congenital Heart Defects
A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Relapsed/ Refractory B-Cell Non-Hodgkin Lymphoma
RecruitingNCT06519162 ↗
Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome
Mitoxantrone Hydrochloride Liposome in Combination With Cytarabine and Venetoclax Regimen in Newly Diagnosed Elderly AML
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →